Latest News Releases 20 January

The CDC estimates more than 2.8 million Americans experience antibiotic-resistant infections each year. To address this critical issue, a team of TTUHSC researchers led by Hongjun (Henry) Liang, Ph.D., recently investigated whether or not a series of novel nanoparticles can kill some pathogens that lead to infection without affecting healthy cells. The study, “Hydrophilic Nanoparticles that Kill Bacteria while Sparing Mammalian Cells Reveal the Antibiotic Role of Nanostructures,” was published Jan. 11 by Nature Communications.

The University of Alabama at Birmingham Marnix E. Heersink School of Medicine announces today the first peer-reviewed research outlining the successful transplant of genetically modified, clinical-grade pig kidneys into a brain-dead human individual, replacing the recipient’s native kidneys. These positive results demonstrate how xenotransplantation could address the worldwide organ shortage crisis.

The University of Alabama at Birmingham Marnix E. Heersink School of Medicine announces today the first peer-reviewed research outlining the successful transplant of genetically modified, clinical-grade pig kidneys into a brain-dead human individual, replacing the recipient’s native kidneys. These positive results demonstrate how xenotransplantation could address the worldwide organ shortage crisis.

CENTOGENE Joins Forces With Insilico Medicine for Niemann-Pick Disease Type C (NPC) Target Discovery, Applying Artificial Intelligence (AI) to Accelerate Orphan Drug Development

Black eyed peas’ ability to attract beneficial bacteria isn’t diminished by modern farming practices, new UC Riverside research shows. Planting it in rotation with other crops could help growers avoid the need for costly, environmentally damaging fertilizers.

Researchers from MD Anderson and Northwestern University have identified natural extracellular vesicles containing the ACE2 protein in the blood of COVID-19 patients that act as decoys to block infection from SARS-CoV-2.